System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Sabina Signoretti is an expert in Oncology at Brigham and Women's Hospital (United States). As of October 2026, ScienceLeadR ranks Sabina Signoretti in the top 1% of experts worldwide for Kidney Neoplasms, Urologic Neoplasms and Carcinoma. Sabina Signoretti has authored 549 publications, the most recent in 2026, and is an investigator in 10 clinical trials. SLR score: 2,054 (community average: 125). How the SLR is computed.

LeadR Profile

Sabina Signoretti Brigham and Women's Hospital United States
2 054 ScienceLeadR Reputation 2054

Unlock

Register Login
Network Map

Oncology

Subspecialties: Genetics - Immunology - Nephrology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1999 - 2026
Source: PubMed

Brigham and Women's Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 549

Citations

Citations: 82 111 1st author: 17 Last author: 50 Unique author: 0

Main journals

J Clin Oncol 107
Cancer Res 36
Nat Commun 28
Nature 25
Clin Cancer Res 24

Best Journals

J Clin Oncol 51
Nature 25
Cell 11

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma.
PMID 42786155 — cells, biological science disciplines, neoplasms, carcinoma, renal cell		Nat Commun20260
Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation.
PMID 42611544 — genes, lung, neoplasms, therapeutics		J Clin Invest20260
PASTA: versatile tyramide-oligonucleotide amplification for multimodal spatial biology.
PMID 42608461 — oligonucleotides		Nat Methods Top journal20260
Molecular and Immune Correlates of Lymphocyte Activation Gene-3 Expression in Renal Cell Carcinoma.
PMID 42578740 — lymphocyte activation, cells, genes, lymphocytes, neoplasms, carcinoma, renal cell, biomarkers		Oncologist20260
A compendium of next-generation patient-derived models for diverse cancers.
PMID 42557316 — neoplasms, therapeutics		Nature Top journal20267

Clinical Studies 10

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 5
Phase 3 4
Phase 1 1

By status:

Completed 6
Active not recruiting 4

By type:

Interventional 10

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 2
multicentric5to9 2
multicentricup10 5

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS